severe cases – Page 23 – Communicable Diseases Research

Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients

Article

Published on 2021-04-132022-10-04
Journal: Cell Discovery [Category] 변종, 진단, 치료기술,

Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data

Research Article

Published on 2021-04-122022-10-29
Journal: Infectious Diseases of Poverty [Category] COVID-19, MERS,

The role of CD4 + FoxP3 + regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment

COVID-19의 면역 병인 발생에서 CD4 + FoxP3 + 조절 T 세포의 역할: 치료에 대한 의미

Review

Published on 2021-04-102022-08-31
Journal: International Journal of Biological Sciences [Category] MERS, SARS, 바이오마커,

[키워드] “cytokine storm” acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus adalimumab addressed Antiviral ARDS attenuation Azithromycin CD4 CD4⁺FoxP3⁺ regulatory T cells Chloroquine Coagulopathy coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 cytokine Cytokine release syndrome Cytokine storm Defense deficiencies deficiency Dexamethasone early stage FOXP3 Hydroxychloroquine IL-2 immune Immune homeostasis immune response immune responses Immunopathogenesis immunopathology implication Infection Inflammatory responses introduced involved late stage low dose maintenance mechanisms organ damage organ injury Patient Perspective problem problems Regulatory Regulatory T cell regulatory T cells respiratory respiratory distress Respiratory distress syndrome sarilumab SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Severe case severe cases syndrome T cell T cells tetrandrine therapeutic agent therapeutic agents Therapies Tocilizumab transfer Treatment Treg Treg cell Treg cells Tregs Vitamin D
[DOI] 10.7150/ijbs.59534 PMC 바로가기 [Article Type] Review

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients

Review

Published on 2021-04-062022-10-28
Journal: Pharmaceuticals [Category] COVID-19,

Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome

급성호흡곤란증후군 중증 코로나19 환자에서 회복기 혈장치료제의 효능 및 안전성

Clinical Trial

Published on 2021-04-012022-09-11
Journal: International immunopharmacology [Category] SARS, 임상, 치료제,

[키워드] acute respiratory distress acute respiratory distress syndrome administration affecting APACHE II ARDS Care Clinical outcome clinical response condition confirmed case contribute control group convalescent plasma Convalescent plasma therapy COVID-19 Critical critical state develop disease severity early administration effective Efficacy evaluate evaluated Health Health care ICU improvement Improvements increase in intubation investigated less Mild moderate mortality rate Noninvasive ventilation outcome Oxygenation passive immunization Patient plasma plasma therapy Randomly receiving reduction in reduction in mortality resources respiratory distress risk Safe SARS-COV-2 infection Severe case severe cases severe COVID-19 severe COVID-19 patient severe COVID-19 patients SOFA SPSS software statistically significant syndrome therapeutic option therapeutic options therapy Treatment was performed
[DOI] 10.1016/j.intimp.2020.107239 PMC 바로가기 [Article Type] Clinical Trial

Compassionate use of remdesivir in children with COVID-19

COVID-19에 걸린 어린이를 위한 렘데시비르의 자비로운 사용

Observational Study

Published on 2021-04-012022-08-31
Journal: European journal of pediatrics [Category] 신약개발, 임상, 치료제,

[키워드] adverse events adverse outcome adverse outcomes age approved Bacterial sepsis children children with COVID-19 clinical Clinical outcome clinical status clinical trials Cohort complex Complication complications conducted COVID-19 COVID-19 cases COVID-19 disease Critically ill death demonstrated died drug effective Efficacy eight first COVID-19 symptom Infant Infants intensive care unit IQR Medical conditions multicenter observational study multicentre observational study Older on children one patient pandemic Patient patients Pediatric patients pharmacokinetics RDV reached receiving Remdesivir reported SARS-CoV-2 Sepsis severe cases severe COVID-19 disease severe disease Spain the patient therapy Tolerability treat Treatment Trial with COVID-19
[DOI] 10.1007/s00431-020-03876-1 PMC 바로가기 [Article Type] Observational Study

Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

Research Article

Published on 2021-03-302022-10-27
Journal: BMC Neurology [Category] COVID-19,

[키워드] 95% CI 95% confidence interval acute cerebrovascular disease addition age all age groups Analysis article calculate Case report CIs Clinical features CNS Complication complications conducted coronavirus coronavirus disease COVID-19 COVID-19 cases COVID-19 patients criteria CVD database Dizziness elevated eligibility eligible Encephalopathy English English language Frequency Google Scholar headache identify impairment knowledge LDH males manifestation Meta-analysis neurological Neurological involvement neurological manifestation NEUROLOGY Non-severe case outcome outcomes Patient patients patients with COVID-19 percentage Result Sample size severe cases severity significantly more subgroup analysis supplementary material systematic review translated was performed was used Web of Science were assessed
[DOI] 10.1186/s12883-021-02161-4 PMC 바로가기 [Article Type] Research Article

Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

Research Article

Published on 2021-03-302022-10-27
Journal: BMC Neurology [Category] Coronavirus, COVID-19, SARS,

[키워드] 95% CI 95% confidence interval acute cerebrovascular disease addition age all age groups Analysis article calculate Case report CIs Clinical features CNS Complication complications conducted coronavirus coronavirus disease COVID-19 COVID-19 cases COVID-19 patients criteria CVD database Dizziness elevated eligibility eligible Encephalopathy English English language Frequency Google Scholar headache identify impairment knowledge LDH males manifestation Meta-analysis neurological Neurological involvement neurological manifestation NEUROLOGY Non-severe case outcome outcomes Patient patients patients with COVID-19 percentage Result Sample size severe cases severity significantly more subgroup analysis supplementary material systematic review translated was performed was used Web of Science were assessed
[DOI] 10.1186/s12883-021-02161-4 PMC 바로가기 [Article Type] Research Article

Chest CT manifestations with emphasis on the role of CT scoring and serum ferritin/lactate dehydrogenase in prognosis of coronavirus disease 2019 (COVID-19)

Research

Published on 2021-03-302022-10-31
Journal: The Egyptian Journal of Radiology and Nuclear Medicine [Category] COVID-19,

COVID-19 in Children: Respiratory Involvement and Some Differences With the Adults

Pediatrics

Published on 2021-03-292022-10-31
Journal: Frontiers in Pediatrics [Category] COVID-19,